Cardiovascular

New Study Reveals Ineffectiveness of Vehicle Exhaust Filters in Removing “Ultrafine” Pollution

Source Node: https://platodata.network/platowire/new-study-reveals-ineffectiveness-of-vehicle-exhaust-filters-in-removing-ultrafine-pollution/
Time Stamp: April 3, 2023 4:57 PM - Modified On: April 3, 2023 - Published By:
Source Cluster:
Republished By Plato

A new study has revealed that vehicle exhaust filters may not be as effective in removing "ultrafine" pollution as previously thought. The study, conducted by researchers at the University of California, Riverside, found that while filters can remove larger particles from exhaust emissions, they are less effective at capturing ultrafine particles that are smaller than 100 nanometers in diameter.Ultrafine particles are a major concern for public health because they can penetrate deep into the lungs and even enter the bloodstream, causing a range of health problems including respiratory and cardiovascular

E-Bikes: A Cost-Effective Alternative to Overpriced Used Cars

Source Node: https://zephyrnet.com/used-cars-are-stupid-expensive-again-e-bikes-could-save-the-day/
Time Stamp: March 21, 2023 2:35 PM - Modified On: March 21, 2023 - Published By:
Source Cluster:
Published by Plato

As the cost of owning a car continues to rise, many people are turning to alternative modes of transportation. One such option that has gained popularity in recent years is the electric bike, or e-bike. E-bikes are a cost-effective alternative to overpriced used cars, offering a range of benefits that make them an attractive option for commuters and recreational riders alike.First and foremost, e-bikes are significantly cheaper than cars. According to a study by the American Automobile Association, the average cost of owning a car in the United States is

FDA Clears ReWalk Exoskeleton for Use on Stairs and Curbs

Source Node: https://zephyrnet.com/rewalk-in-globenewswire-advancement-in-rewalk-technology-achieves-fda-clearance-as-only-personal-exoskeleton-to-enable-use-on-stairs-and-curbs/
Time Stamp: March 7, 2023 8:57 AM - Modified On: March 7, 2023 - Published By:
Source Cluster:
Published by Plato

The U.S. Food and Drug Administration (FDA) recently cleared the ReWalk exoskeleton for use on stairs and curbs, making it the first of its kind to receive such clearance. The ReWalk is a motorized, robotic exoskeleton that is designed to help people with lower-limb disabilities walk. The device is worn like a backpack and uses motors and sensors to help the user move their legs. The FDA’s clearance of the ReWalk for use on stairs and curbs is a major milestone for those with lower-limb disabilities. This clearance allows users

COAPT™ Trial Results Demonstrate Long-Term Benefits of Abbott’s MitraClip™ Device

Source Node: https://zephyrnet.com/late-breaking-data-from-landmark-coapt-trial-show-long-term-benefits-of-abbotts-mitraclip-device/
Time Stamp: March 4, 2023 7:00 PM - Modified On: March 4, 2023 - Published By:
Source Cluster:
Published by Plato

for Heart Failure Patients Recent findings from the COAPT™ clinical trial have demonstrated the long-term benefits of Abbott's MitraClip™ device for heart failure patients. The trial, which was conducted by the Cardiovascular Research Foundation, showed that the MitraClip™ device significantly reduced hospitalizations and improved quality of life for patients with heart failure. The MitraClip™ device is a minimally invasive device that is used to treat mitral regurgitation, a condition in which the mitral valve does not close properly and allows blood to flow backward in the heart. The device works

SpectraWAVE HyperVue Intravascular Imaging System Approved by FDA

Source Node: https://zephyrnet.com/fda-approves-spectrawaves-hypervue-intravascular-imaging-system/
Time Stamp: March 2, 2023 10:25 AM - Modified On: March 2, 2023 - Published By:
Source Cluster:
Published by Plato

The U.S. Food and Drug Administration (FDA) has recently approved the SpectraWAVE HyperVue Intravascular Imaging System, a revolutionary new device that allows physicians to diagnose and treat cardiovascular diseases. The device, developed by SpectraWAVE Technologies, is a high-resolution intravascular imaging system that provides real-time images of the interior of blood vessels.The SpectraWAVE HyperVue Intravascular Imaging System is the first device of its kind to be approved by the FDA. It is designed to help physicians diagnose and treat cardiovascular diseases such as coronary artery disease, peripheral artery disease, and stroke.

SpectraWAVE’s HyperVue Intravascular Imaging System Receives FDA Approval

Source Node: https://zephyrnet.com/fda-approves-spectrawaves-hypervue-intravascular-imaging-system/
Time Stamp: March 2, 2023 10:25 AM - Modified On: March 2, 2023 - Published By:
Source Cluster:
Published by Plato

SpectraWAVE, a medical device company, has recently received approval from the U.S. Food and Drug Administration (FDA) for its HyperVue Intravascular Imaging System. This system is a revolutionary new imaging technology that provides physicians with high-resolution images of the inside of blood vessels. This technology has the potential to revolutionize the diagnosis and treatment of cardiovascular diseases. The HyperVue Intravascular Imaging System is a catheter-based imaging system that utilizes a combination of ultrasound, optical coherence tomography (OCT), and near-infrared spectroscopy (NIRS) to provide detailed images of the interior of blood